Us Nuclear Financials
This page shows Us Nuclear (UCLE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Product-level margins improved, but overhead growth and external financing still govern how this business stays operating.
From FY2023 to FY2024, net loss nearly halved to-$1.7M , yet operating cash burn worsened to-$509K . With only$131K of cash and$518K from financing, day-to-day liquidity still depended on external funding rather than on the reported earnings improvement.
The notable shift is at the gross margin line, which reached
The balance sheet behaves like an inventory-funded business with very little cash cushion: inventory of
Financial Health Signals
Based on FY2024 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Us Nuclear's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Us Nuclear has an operating margin of -70.1%, meaning the company retains $-70 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -73.6% the prior year.
Us Nuclear's revenue declined 1.8% year-over-year, from $2.2M to $2.2M. This contraction results in a growth score of 37/100.
Us Nuclear has elevated debt relative to equity (D/E of -1.77), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
Us Nuclear's current ratio of 0.77 is below the typical benchmark, resulting in a score of 10/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Us Nuclear passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Us Nuclear generates $0.29 in operating cash flow (-$509K OCF vs -$1.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Us Nuclear earns $-6.8 in operating income for every $1 of interest expense (-$1.5M vs $225K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Us Nuclear generated $2.2M in revenue in fiscal year 2024. This represents a decrease of 1.8% from the prior year.
Us Nuclear's EBITDA was -$1.5M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.4% from the prior year.
Us Nuclear reported -$1.7M in net income in fiscal year 2024. This represents an increase of 49.3% from the prior year.
Us Nuclear earned $-0.04 per diluted share (EPS) in fiscal year 2024. This represents an increase of 60.0% from the prior year.
Cash & Balance Sheet
Us Nuclear held $131K in cash against $1.5M in long-term debt as of fiscal year 2024.
Us Nuclear had 51M shares outstanding in fiscal year 2024. This represents an increase of 32.4% from the prior year.
Margins & Returns
Us Nuclear's gross margin was 46.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 4.9 percentage points from the prior year.
Us Nuclear's operating margin was -70.1% in fiscal year 2024, reflecting core business profitability. This is up 3.5 percentage points from the prior year.
Us Nuclear's net profit margin was -79.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 74.5 percentage points from the prior year.
Capital Allocation
UCLE Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $595K+33.2% | $447K-6.2% | $477K+6.1% | $449K-26.5% | $611K+21.5% | $503K-19.9% | $628K-2.4% | $643K |
| Cost of Revenue | $296K+49.8% | $198K+54.7% | $128K-75.3% | $518K+274.8% | $138K-43.3% | $244K-10.9% | $274K-58.2% | $655K |
| Gross Profit | $299K+20.0% | $249K-28.5% | $349K+604.7% | -$69K-114.6% | $473K+82.8% | $258K-26.9% | $354K+3120.8% | -$12K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $558K+37.5% | $405K-53.5% | $873K+107519.9% | $811-99.9% | $542K-12.9% | $622K+24.8% | $498K+200.1% | -$498K |
| Operating Income | -$258K-65.5% | -$156K+70.2% | -$524K+45.3% | -$958K-1285.2% | -$69K+81.0% | -$363K-151.5% | -$144K+79.4% | -$702K |
| Interest Expense | $69K+150.3% | $28K-23.9% | $36K-33.2% | $54K+30.3% | $42K-54.7% | $92K+147.7% | $37K-84.3% | $237K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $147K+170.9% | -$208K+62.9% | -$560K+44.6% | -$1.0M-812.0% | -$111K+75.6% | -$455K-181.2% | -$162K+85.8% | -$1.1M |
| EPS (Diluted) | $0.00+100.0% | $-0.010.0% | $-0.01 | N/A | $0.00+100.0% | $-0.01 | $0.00 | N/A |
UCLE Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.5M+1.3% | $2.5M+0.3% | $2.5M-5.6% | $2.6M-14.1% | $3.1M+8.4% | $2.8M-2.2% | $2.9M+1.8% | $2.9M |
| Current Assets | $2.0M+1.7% | $1.9M+0.4% | $1.9M-7.2% | $2.1M-17.4% | $2.5M+10.6% | $2.3M-2.7% | $2.3M+2.3% | $2.3M |
| Cash & Equivalents | $76K+64.0% | $46K-32.4% | $68K-47.7% | $131K+311.7% | $32K-76.9% | $138K+4.3% | $132K-13.5% | $153K |
| Inventory | $1.7M-5.5% | $1.8M+3.1% | $1.8M+13.9% | $1.5M-21.9% | $2.0M+8.7% | $1.8M+1.4% | $1.8M+1.3% | $1.8M |
| Accounts Receivable | $130K+237.2% | $39K-36.8% | $61K-82.6% | $351K-24.3% | $464K+65.9% | $280K-28.1% | $389K+13.7% | $342K |
| Goodwill | $570K0.0% | $570K0.0% | $570K0.0% | $570K0.0% | $570K0.0% | $570K0.0% | $570K0.0% | $570K |
| Total Liabilities | $2.4M-26.6% | $3.3M+2.4% | $3.2M-9.2% | $3.5M+8.5% | $3.2M-37.4% | $5.2M+3.6% | $5.0M+2.9% | $4.8M |
| Current Liabilities | $2.2M-8.8% | $2.5M+3.2% | $2.4M-12.0% | $2.7M+11.8% | $2.4M-53.2% | $5.2M+3.6% | $5.0M+2.9% | $4.8M |
| Long-Term Debt | $347K-68.2% | $1.1M-8.5% | $1.2M-21.2% | $1.5M+136.7% | $638K-3.8% | $664K+0.6% | $660K+15.7% | $570K |
| Total Equity | $146K+119.5% | -$751K-10.0% | -$683K+20.3% | -$856K-488.1% | -$146K+93.7% | -$2.3M-11.7% | -$2.1M-4.5% | -$2.0M |
| Retained Earnings | -$20.5M+0.5% | -$20.6M-1.2% | -$20.3M-3.2% | -$19.7M-5.8% | -$18.6M-0.6% | -$18.5M-2.5% | -$18.0M+2.9% | -$18.6M |
UCLE Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $150K+197.7% | -$154K-66.1% | -$92K-10.7% | -$84K+64.6% | -$236K-135.4% | -$100K-13.4% | -$89K+45.0% | -$161K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | -$9K-162.5% | -$4K+75.2% | -$14K-257.7% | -$4K-5.1% | -$4K |
| Financing Cash Flow | -$121K-191.7% | $131K+336.1% | $30K-84.3% | $192K+43.3% | $134K+11.3% | $120K+67.3% | $72K-46.0% | $133K |
| Dividends Paid | -$96K-351.7% | $38K-56.3% | $87K | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
UCLE Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 50.2%-5.5pp | 55.8%-17.4pp | 73.2%+88.6pp | -15.4%-92.8pp | 77.4%+25.9pp | 51.4%-4.9pp | 56.4%+58.2pp | -1.8% |
| Operating Margin | -43.4%-8.5pp | -34.9%+75.0pp | -109.9%+103.4pp | -213.3%-202.0pp | -11.3%+60.9pp | -72.3%-49.3pp | -23.0%+86.2pp | -109.2% |
| Net Margin | 24.8%+71.2pp | -46.5%+71.0pp | -117.5%+107.7pp | -225.2%-207.0pp | -18.2%+72.5pp | -90.6%-64.8pp | -25.8%+151.1pp | -176.9% |
| Return on Equity | 100.7% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 5.8%+14.1pp | -8.3%+14.1pp | -22.4%+15.8pp | -38.2%-34.6pp | -3.6%+12.4pp | -16.0%-10.4pp | -5.6%+34.3pp | -39.8% |
| Current Ratio | 0.88+0.1 | 0.79-0.0 | 0.81+0.0 | 0.77-0.3 | 1.04+0.6 | 0.44-0.0 | 0.470.0 | 0.47 |
| Debt-to-Equity | 2.37+3.8 | -1.45+0.3 | -1.74+0.0 | -1.77+2.6 | -4.39-4.1 | -0.29+0.0 | -0.32-0.0 | -0.29 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$856K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.77), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Us Nuclear's annual revenue?
Us Nuclear (UCLE) reported $2.2M in total revenue for fiscal year 2024. This represents a -1.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Us Nuclear's revenue growing?
Us Nuclear (UCLE) revenue declined by 1.8% year-over-year, from $2.2M to $2.2M in fiscal year 2024.
Is Us Nuclear profitable?
No, Us Nuclear (UCLE) reported a net income of -$1.7M in fiscal year 2024, with a net profit margin of -79.4%.
What is Us Nuclear's EBITDA?
Us Nuclear (UCLE) had EBITDA of -$1.5M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Us Nuclear have?
As of fiscal year 2024, Us Nuclear (UCLE) had $131K in cash and equivalents against $1.5M in long-term debt.
What is Us Nuclear's gross margin?
Us Nuclear (UCLE) had a gross margin of 46.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Us Nuclear's operating margin?
Us Nuclear (UCLE) had an operating margin of -70.1% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Us Nuclear's net profit margin?
Us Nuclear (UCLE) had a net profit margin of -79.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Us Nuclear's operating cash flow?
Us Nuclear (UCLE) generated -$509K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Us Nuclear's total assets?
Us Nuclear (UCLE) had $2.6M in total assets as of fiscal year 2024, including both current and long-term assets.
What is Us Nuclear's current ratio?
Us Nuclear (UCLE) had a current ratio of 0.77 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Us Nuclear's debt-to-equity ratio?
Us Nuclear (UCLE) had a debt-to-equity ratio of -1.77 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Us Nuclear's return on assets (ROA)?
Us Nuclear (UCLE) had a return on assets of -65.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Us Nuclear's cash runway?
Based on fiscal year 2024 data, Us Nuclear (UCLE) had $131K in cash against an annual operating cash burn of $509K. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Us Nuclear's debt-to-equity ratio negative or unusual?
Us Nuclear (UCLE) has negative shareholder equity of -$856K as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Us Nuclear's Piotroski F-Score?
Us Nuclear (UCLE) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Us Nuclear's earnings high quality?
Us Nuclear (UCLE) has an earnings quality ratio of 0.29x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Us Nuclear cover its interest payments?
Us Nuclear (UCLE) has an interest coverage ratio of -6.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Us Nuclear?
Us Nuclear (UCLE) scores 8 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.